FDA Webview
X

Free FDA Notices

Delcobese Not Withdrawn for S&E

11/10/2003
Federal Register Notice: FDA has determined that Delcobese (amphetamine adipate, amphetamine sulfate, dextroamphetamine adipate, dextroamphetamine sulfate) tablets and capsules were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications for generic versions of Delcobese tablets and capsules. To view this notice, click here.

LATEST NEWS